Today, 1 March 2024, the ELIXIR Hub welcomes Tim Hubbard in his new role as ELIXIR Director. Andy Smith remains Interim Director until 31 May, with responsibilities gradually transitioning to Tim.
Tim joins ELIXIR from King's College London where he was Professor of Bioinformatics in the Department of Medical and Molecular Genetics. He has also acted as Senior Advisor at Genomics England and Associate Director of the London region of Health Data Research UK (HDR UK).
Andy welcomed Tim to ELIXIR, saying “We are delighted that Tim has joined ELIXIR as our new Director. We are at an important phase in ELIXIR’s operations, with the implementation of our 2024-28 Scientific Programme now underway. Tim’s long-term vision and experience in bioinformatics service delivery will help ensure that these activities bring value to ELIXIR’s stakeholders across Europe and beyond”.
Alexander Goesmann, Chair of the ELIXIR Board, commented “The Board warmly welcome Tim as ELIXIR’s new Director. Based on his many years of experience, we are confident that ELIXIR is in capable hands. The Board looks forward to working with Tim and wish him well as he starts in his new role.”
Tim said “It’s exciting to be starting at ELIXIR today at the beginning of the 2024-28 Programme, with new European-wide initiatives in molecular data, software and services. There are huge opportunities for the future use of biomedical data, such as through the increasingly pervasive impact of artificial intelligence and initiatives such as the European Health Data Space. The ELIXIR infrastructure can play a major enabling role, helping maximise the benefit for all”.
Tim replaces Niklas Blomberg, ELIXIR’s founding Director, who started a new role as Executive Director of the Innovative Health Initiative (IHI) in January 2024.
Find out more
Tim Hubbard to be new ELIXIR Director